FDA Civil Penalties For Human Subject Violations Considered By Kennedy
Executive Summary
Legislation granting FDA the authority to levy civil monetary penalties against researchers and institutions violating federal human subjects protections could be introduced by Sen. Kennedy (D-Mass.) before the end of the year.
You may also be interested in...
GAO Financial Conflict Of Interest Report Planned For Mid-July
The General Accounting Office plans to issue a report on financial conflict of interest in clinical research in mid-July.
GAO Financial Conflict Of Interest Report Planned For Mid-July
The General Accounting Office plans to issue a report on financial conflict of interest in clinical research in mid-July.
FDA Clinical Site Inspections Should Look At Recruitment Tactics - IG Report
FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.